期刊文献+

缺氧诱导因子-1和血管内皮生长因子及其受体家族对妊娠期高血压疾病发生的研究进展 被引量:13

Progress in research of hypoxia inducing factor-1, vascular endothelial growth factor and its receptor family with hypertensive disorder complicating pregnancy
原文传递
导出
摘要 妊娠期高血压疾病是妊娠期特有的疾病,是导致孕产妇及围生儿死亡率升高的主要原因。由于病因和发病机制尚未完全明确,普遍认为胎盘损伤是发病的中心环节。近年来,有研究表明,缺氧诱导因子-1(hypoxiainduciblefactor-1,HIF一1)、血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)及其受体家族是妊娠期高血压疾病相关的重要调节因子,文中主要对这两种调节因子及二者与妊娠期高血压疾病的关系进行综述。 Hypertensive disorder complicating pregnancy is a special disease during pregnancy, and it is the key reason for rising death rate of maternal and perinatal infants. Its etiology and pathogenesis are not yet fully elucidated. It is generally accepted that placenta damage plays a central role in hypertensive disorders complicating pregnancy. In recent years, studies have shown that hypoxia inducing factor-1 (HIF-1), vascular endothelial growth factor (VEGF)and its receptor family are important regulatory factors associated with hypertensive disorders complicating pregnancy. In this article, we discussed the relationship between the two factors and hypertensive disorders complicating pregnancy.
出处 《中华地方病学杂志》 CAS CSCD 北大核心 2016年第3期231-234,共4页 Chinese Journal of Endemiology
关键词 高血压 妊娠性 缺氧诱导因子-1 血管内皮生长因子 Hypertension, pregnancy-induced Hypoxia inducible factor-1 Vascular endothelialgrowth factor
作者简介 通信作者:蔡丽瑛,Email:doctorcly@hotmail.com
  • 相关文献

参考文献1

二级参考文献43

  • 1Kubo H, Fujiwara T, Jussila L, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 2000; 96:546-553.
  • 2Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008; 454:656-660.
  • 3Dumont D J, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998; 282:946-949.
  • 4Hamada K, Oike Y, Takakura N, et al. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 2000; 96:3793-3800.
  • 5Haiko P, Makinen T, Keskitalo S, et al. Deletion of vascular endothelial growth factor (VEGF-C) and VEGF-D is not equivalent to VEGFR-3-null in mouse embryos, Mol Cell Biol 2008; 28:4843-4850.
  • 6Lakso M, Pichel JG, Gorman JR, et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA 1996; 93:5860-5865.
  • 7Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144:789-801.
  • 8Gordon E J, Gale NW, Harvey NL. Expression of the hyaluronan receptor LYVE-l is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev Dyn 2008; 237:1901-1909.
  • 9Karkkainen M J, Saaristo A, Jussila L, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001; 98:12677-12682.
  • 10Zhang X, Groopman JE, Wang JF. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. J Cell Physiol2005; 202:205-214.

共引文献7

同被引文献131

引证文献13

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部